Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors-Reference-Cited by-同舟云学术

Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors

Published:1989-12 Issue:6 Volume:340 Page:633-638
ISSN:0028-1298
Container-title:Naunyn-Schmiedebergs Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch. Pharmacol.

Author:

Schlicker Eberhard,Fink Klaus,Hinterthaner Marc,G�thert Manfred

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00717738.pdf

Reference11 articles.

1. Arrang J-M, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832?837

2. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283?335

3. Göthert M (1979) Ca2+-induced noradrenaline release from central noradrenergic neurones promoted by high K+ concentration or ionophore A 23187. Naunyn-Schmiedeberg's Arch Pharmacol 307:29?37

4. Schlicker E, Hinterthaner M (1989) Histamine H3 receptor-mediated inhibition of noradrenaline release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 339 (Suppl):R 90

5. Schlicker E, Betz R, Göthert M (1988) Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 337:588?590

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The histamine H3 receptor inverse agonist SAR-152954 reverses deficits in long-term potentiation associated with moderate prenatal alcohol exposure;Alcohol;2024-08

2. Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity;Biomolecules;2024-06-26

3. Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder;Pharmaceuticals;2024-06-25

4. The molecules lost NEW COMPOUNDS BINDING AT THE HISTAMINE SITE OF THE NMDA RECEPTOR (NMDA_(HA)R);2024-03-12

5. 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases;ACS Chemical Neuroscience;2024-03-05